Sunday, September 25, 2016 11:55:21 AM
and clean financial resources-lenders are not willing to broker a deal because of Amarantus's current heinous default crisis under the notorious clutches of Magna
then there 'might be' an out right buyout offer in the making here for ESS
as what prospective owner would want to own part of something dirty, when they can own the whole of it clean
however, without Ph. 2 or Ph. 3 test trial results, what large BioPharma that specializes in engineered substitute skin would put down a substantial offer for part of something that has dirty financing and is yet unknown
only questions remaining are what is "Corporate" doing
and will it be beneficial for shareholders who have already lost literally 99.8% of their investment
the sad truth is that Amaranthus is negotiating from weakness - as opposed to strength
sad but true
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM